Member Info for draft

How much percent been added by the buyer, about 4%?

Clients currently using the Krunch platform include Mortgages for Businesses, The Disasters & Emergency Committee and Unite the Union. And that F1 tie up possibly

Looks like schlomo added 6 grand

Have you watched the krunch ai YouTube presentation. Its pretty smart and I like the tone of the guy presenting. Very personable

I bought loads. They probably will change the ticker.

As a chartered accountant myself, I just don't see this as an issue and they even said in the rns its not a problem

Lol what. The main news is yet to come I think. What about all the Krunch AI tech. I wouldn't be surprised if something happened.

Bought more

I watched a YouTube video by a krunch ai guy. He mentioned formula1 as a client maybe

Eh so what. Who cares. I've been in plenty of suspended stuff. It will come back.

Love the engineered drop to let people Hoover

Gifthorse

Lol your winding him up Quindell. That's probably his 500k sell.

Midatech’s lead development product, MTD201 (Q-Octreotide), is based on the company’s polymer microsphere technology Q-Sphera for sustained release delivery. The novel innovation of Q-Sphera technology allows for higher drug loading, more precise control over drug particle size and morphology, and highly linear reproducible drug release kinetics compared to traditional and older microsphere processes.
The market leader for treatment of carcinoid and acromegaly is Sandostatin LAR™ by Novartis, who dominate this $2bn dollar market. MTD201 Q-Octreotide is being developed as a better interchangeable alternative to SLAR. Exploiting Midatech Pharma’s Q-Sphera platform, the improved sustained-release formulation used in Q-Octreotide is expected to improve injectability, avoid needle blockage, enable the use of smaller needles and reduce injection site pain compared to SLAR.

Following MTD201 dosing, all subjects enter a 63 day observation and sampling period. This data will then be analysed, with top line results expected by the end of 2019 or early in 2020.

On Friday, an official at Shandong Ruyi’s capital operation department told The Wall Street Journal it had paid creditors all the principal and interest due. “The process was bumpy. As you know, banks and financial institutions have been very unfavorable to Shandong enterprises,” said the official, who asked not to be named.
HSBC, the trustee for the bonds, confirmed Friday afternoon that it received $356.9 million, which comprises the bond principal plus interest.
The repayment appeared to surprise even some influential mainland creditors. In a filing late Thursday, Cinda International Holdings, a unit of the Chinese bad-debt manager China Cinda Asset Management, said it had sold its Shandong Ruyi bonds with a face value of $6 million for about 78% of that amount. Cinda said it sold the bonds because there was a risk they wouldn’t be redeemed at maturity.

A Chinese fashion and textile conglomerate unexpectedly repaid dollar bondholders of a maturing dollar bond, after becoming the latest focus of investor concerns about rising corporate defaults in China.

note the unexpected. next unexpectedly we will get paid or get our machinery maybe

Yeah the more I look at the price at that time, it does seem a buy actually

The share price was dropped to fill a buy

Anyway hopefully Mr Ezry will buy some more. He will be more in the know than that pi seller who dumped this morning